Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Breast Surgery
  •  General Surgery
  •  Vascular Surgery
  •  Orthopaedic Surgery
  •  Plastic Surgery
  •  Thoracic Surgery
  •  Neurological Surgery
  •  Obstetrics Surgery

Abstract

Citation: Clin Surg. 2019;4(1):2669.Case Report | Open Access

Subacute Type A Aortic Dissection with 10% of Ejection Fraction

Shinichiro Ikeda, Paul C Saunders and Benjamin A Youdelman

Department of Surgery, Division of Cardiothoracic Surgery, Maimonides Medical Center, USA

*Correspondance to: Shinichiro Ikeda 

 PDF  Full Text DOI: 10.25107/2474-1647.2669

Abstract

A 36-year-old male suffered acute type A aortic dissection complicated with Ejection Fraction (EF) of less than 10% without coronary dissection and valvular disease. We decided to manage the heart failure first and when EF improved to 25% one week later, we performed ascending aorta replacement as this was subacute aortic dissection. Although central venous arterial extracorporeal membrane oxygenation support was needed for one day and the patient had embolic stroke on postoperative day 9, the patient was discharged to the rehabilitation center on postoperative day 22. The symptom of stroke was almost resolved at 6-month follow-up.

Keywords

Subacute type A aortic dissection; Low ejection fraction; CT

Cite the article

Ikeda S, Saunders PC, Youdelman BA. Subacute Type A Aortic Dissection with 10% of Ejection Fraction. Clin Surg. 2019; 4: 2669.

Search Our Journal

Journal Indexed In

Articles in PubMed

Monitoring an Ongoing Enhanced Recovery after Surgery (ERAS) Program: Adherence Improves Clinical Outcomes in a Comparison of Three Thousand Colorectal Cases
 PubMed  PMC  PDF  Full Text
Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Review of the Latest Methods in the Treatment of Epidermolysis Bullosa and Other Chronic Wounds, Development of Innovative Advanced Therapy Medicinal Product
 Abstract  PDF  Full Text
Discordance between Deep Remissions Assessed by MRI and Long-term Clinical Remission after Combined Therapy with Infliximab and Seton Placement for Perianal Fistulizing Crohn's Disease
 Abstract  PDF  Full Text
View More...